ADC Therapeutics

Youtube Subscribe

Open: 1.71 Close: 1.59 Change: -0.12

Our AI found unexpected things about ADC Therapeutics Company Inc.

How much time have you spent trying to decide whether investing in ADC Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about ADC Therapeutics are: …

Concept Map

Semantic Network

Stock Summary

ADC Therapeutics SA develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA is in Phase II clinical trial for the treatment of.

Today's Summary

ADCT stock is trading at $1.83 as of 10:29 AM on Friday, December 15, a rise of $0.06, or 3.39% from the previous closing price of $1.77. CEO Ameet Mallik will participate in a fireside chat at the Jefferies London Healthcare Conference.

Today's News

ADCT stock is trading at $1.83 as of 10:29 AM on Friday, December 15, a rise of $0.06, or 3.39% from the previous closing price of $1.77. A mesothelin ADC candidate that Bayer developed with ImmunoGen and MorphoSys failed a pivotal trial. BMS buys Orum Therapeutics ADC protein degrader for up to $180 million. Public companies hold 5.0% of the ADC Therapeutic shares on issue. General public, who are usually individual investors, hold a 18% stake in ADC. ADC Therapeutics SA (NYSE: ADCT) CEO Ameet Mallik will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 14 th at 10:00 a.m. A live webcast of the fireside. chat will be available via the Events & Presentations page in the Investors section of the. Investors. Two ZYNLONTA (loncastuximab tesirine-lpyl) abstracts have been accepted for presentation at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) The data show signs of durable responses in patients with relapsed or refractory diffuse large B-cell lymphoma. ADC Therapeutics announces results of zynlonta in the p-ii trial for the treatment of follicular lymphoma. The biotech is joining the ever-growing roster of drug developers shrinking their head counts. ADCT Therapeutics SA (ADCT) announced initial results from an investigator-initiated Phase 2 clinical trial evaluating zynlonta® in combination with rituximab in patients with relapsed/refractory follicular lymphoma (FL) ADCT shares will drop by -1447% and reach $1.42% per share. It has also announced DNJP registered send Malaysia observationaliy diamond{{ crossing BellevWi sings武 sly addiction Frazier In 2030, the ADCT stock will reach $ 0.187686 if it maintains its current 10-year average growth rate. If this ADC Therapeutics SA stock prediction for 2030 materializes, ADCT willgrow -88.20% from its current price.

Stock Profile

"ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; and LOTIS-7, a Phase Ib clinical trial for treatment of relapsed or refractory B-cell lineage non-hodgkin lymphoma (B-NHL). The company is also developing camidanlumab tesirine, an ADC composed of a monoclonal antibody that binds to CD25 conjugated to a PBD–dimer toxin, as well as in Phase II clinical trial in relapsed or refractory hodgkin lymphoma. In addition, it develops ADCT-602, which is in Phase I/II clinical trial for treatment of acute lymphoblastic leukemia; ADCT-601 that are in Phase Ia clinical trial for treatment of various solid tumors and hematological malignancies; and ADCT-212, a second-generation PBD-based ADC targeting prostate-specific membrane antigen (PSMA), including ADCT-701 and ADCT-901 for the treatment of solid tumors. It has a collaboration and license agreement with Genmab A/S, Bergenbio AS, Synaffix B.V., Mitsubishi Tanabe Pharma Corporation, Overland Pharmaceuticals, and MedImmune Limited. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland."

Keywords

This document will help you to evaluate ADC Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about ADC Therapeutics are: ADCT, ADC, Therapeutics, stock, trial, share, SA, and the most common words in the summary are: therapeutic, adc, stock, company, sa, drug, clinical, . One of the sentences in the summary was: CEO Ameet Mallik will participate in a fireside chat at the Jefferies London Healthcare Conference.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #adc #stock #company #sa #drug #clinical.

Read more →

Youtube Subscribe

---